Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Submitted by
admin
on February 2, 2012 - 10:08am
Source:
Yahoo/Fly on the Wall
News Tags:
Sucampo
Lubiprostone
OBD
opioid-induced bowel dysfunction
Headline:
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Do Not Allow Advertisers to Use My Personal information
